Trials / Completed
CompletedNCT02310048
Comparative Oral Bioavailability Study of MT-1303
A Randomised, Open-Label, Single-Dose, Parallel Group Study to Assess the Comparative Oral Bioavailability of Two Capsule Formulations of MT-1303 in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Tanabe Pharma Corporation · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the comparative oral bioavailability of a Formulation B versus the Formulation A of MT-1303.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MT-1303-FormA | |
| DRUG | MT-1303-FormB |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2015-03-01
- Completion
- 2015-03-01
- First posted
- 2014-12-05
- Last updated
- 2015-03-17
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02310048. Inclusion in this directory is not an endorsement.